Transhepatic-intrahepatic branches of the portal vein catheterization for ex vivo liver resection and autotransplantation: Two case reports of novel approach to perfuse the liver.

Medicine (Baltimore) 2019 Mar;98(11):e14706

Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, PR China.

Rationale: There has been increased use of ex vivo liver resection and autotransplantation (ERAT) for treatment of end-stage hepatic alveolar echinococcosis (HAE). Rapid perfusion of the autograft in bench resection is always required to reduce the warm ischemia time (WIT) and to protect the function of the remnant liver. Nevertheless, the severe invasion of the portal hepatis sometimes makes it impossible to find a usable inflow rapidly and the process of perfusion could be delayed.

Patient Concerns: Two patients diagnosed with end-stage HAE combined with severe portal hepatis invasion were selected to undergo ERAT at our center.

Diagnosis: Besides the large HAE lesions, the CT imaging of patient 1 showed that part of the intra- and extrahepatic portal vein (PV) had disappeared. Patient 2 had severe invasion of both of the right and left branches of the PV.

Interventions: We introduced a new approach for perfusing the liver in ERAT using transhepatic-intrahepatic branches of the PV catheterization. Afterward, ERAT was successfully performed.

Outcomes: For patient 1, the WIT was 2 minutes and the cold ischemia time (CIT) was 296 minutes. For patient 2, the WIT was 2 minutes and the CIT was 374 minutes. Patient 1 suffered stenosis of the common bile duct on postoperative day 14, and patient 2 recovered uneventfully. Both of the 2 patients were discharged from the hospital with normal laboratory values on postoperative day 31 and 15, respectively. The laboratory values for both patients at recent follow-up were normal.

Lessons: Transhepatic-intrahepatic branches of the PV catheterization is useful for decreasing WIT and facilitating the management of ERAT. It is a useful technical variant that could be used in ERAT for treating patients with severe portal hepatis invasion.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000014706DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426561PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
March 2019
3 Reads

Publication Analysis

Top Keywords

portal hepatis
12
transhepatic-intrahepatic branches
12
hepatis invasion
8
laboratory values
8
resection autotransplantation
8
severe portal
8
postoperative day
8
ischemia time
8
patient wit
8
wit minutes
8
branches catheterization
8
minutes patient
8
liver resection
8
severe invasion
8
portal vein
8
vivo liver
8
erat
6
patient
6
portal
5
liver
5

Similar Publications